Effects of optimized heart failure medication on central sleep apnea with Cheyne-Stokes respiration pattern in chronic heart failure with reduced left-ventricular ejection fraction.
Journal
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
ISSN: 2694-0604
Titre abrégé: Annu Int Conf IEEE Eng Med Biol Soc
Pays: United States
ID NLM: 101763872
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
entrez:
18
1
2020
pubmed:
18
1
2020
medline:
9
6
2020
Statut:
ppublish
Résumé
Central Sleep Apnea with Cheyne Stokes Respiration (CSA-CSR) is often diagnosed in patients with chronic heart failure (CHF). CSA-CSR displays a periodic breathing pattern with a typical waxing and waning breathing with central sleep apnea phases in between. Optimization of heart failure medication with Angiotensin receptor neprilysin inhibition (ARNi) can effect phenotypic traits of CSA-CSR indicating improvements of both, hemodynamic parameters and central chemosensitivity.
Identifiants
pubmed: 31947152
doi: 10.1109/EMBC.2019.8857849
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM